Clinical Trials List
Protocol Number3200K-3361-AP
Not yet recruiting
2009-06-01 - 2010-12-31
Phase III
Terminated3
-
Trial Applicant
Wyeth-Ayerst (Asia) LLC
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Jen-Shi Chen Division of Hematology & Oncology
- Chi-Ting Liau Division of Hematology & Oncology
- Hung-Ming Wang Division of Hematology & Oncology
- Wen-Cheng Chang Division of Hematology & Oncology
- 廖宗琦 Division of Hematology & Oncology
- Tsai-Sheng Yang Division of Hematology & Oncology
- Hung-Chih Hsu Division of Hematology & Oncology
- Hsien-Kun Chang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Wei-Hsin Chiu Division of Anesthesia
- 徐正源 Division of Anesthesia
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林豐盛醫師 Division of Anesthesia
- 林豐盛 Division of Anesthesia
- CHIH-PENG LIN Division of Anesthesia
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
300 participants
